Related Experiment Video
Updated: Jul 20, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
A simple and reliable method to assess heart viability after hypothermic procurement
R Ferrera1, J-C Bopassa, C Rodriguez
1INSERM EMI-U 0226, Laboratoire de Physiologie, Faculté de médecine Lyon-Nord, 8 avenue Rockefeller, 69373 Lyon Cedex 08, France. ferrera@lyon.inserm.fr
This study demonstrates that measuring the initial blood flow through the heart's arteries immediately after cold preservation provides a reliable way to predict how well a donor heart will function after transplantation. By testing hearts from pigs subjected to different periods of warm ischemia, researchers found that this simple flow measurement correlates strongly with heart energy levels and subsequent performance, offering a practical tool for assessing organ quality before surgery.
Area of Science:
- Cardiovascular physiology within heart viability research
- Transplant medicine and surgical innovation
Background:
No reliable, rapid diagnostic tool currently exists to assess the functional health of donor hearts prior to transplantation. That uncertainty drove researchers to investigate objective markers of organ quality during the procurement process. Prior research has shown that warm ischemia significantly degrades myocardial tissue integrity and metabolic capacity. However, clinical teams often lack a standardized, real-time metric to quantify this damage before proceeding with surgery. This gap motivated the development of simple, perfusion-based assessments to predict post-transplant outcomes. Most existing methods for evaluating graft viability require complex, time-consuming laboratory analyses that are impractical in urgent clinical settings. Previous studies have highlighted the importance of coronary vascular resistance as a potential indicator of ischemic injury. This study addresses the need for a straightforward, quantifiable measurement to guide surgical decision-making during heart procurement.
Purpose Of The Study:
The aim of this study was to establish a reliable, simple method for assessing donor heart viability prior to transplantation. Researchers sought to address the lack of objective, real-time metrics for evaluating cardiac graft quality after procurement. The team hypothesized that initial coronary flow could serve as a surrogate marker for the extent of ischemic damage. By subjecting donor hearts to varying durations of warm ischemia, the investigators aimed to quantify the impact on vascular resistance. This work was motivated by the need to improve donor organ selection and reduce post-transplant complications. The study specifically examined whether flow measurements correlate with metabolic energetic indices and subsequent functional recovery. No prior work had resolved the utility of this specific perfusion metric in a controlled, orthotopic transplant model. This investigation provides a standardized approach to verify that a donor heart remains suitable for clinical use.
Main Methods:
The investigators utilized a porcine model to evaluate cardiac function following varying durations of warm ischemia. Eighteen brain-dead animals were divided into three distinct groups based on the length of ischemic exposure. Following organ harvesting, the team administered cold cardioplegia solution using a retrograde perfusion technique. The research approach involved measuring the initial coronary flow rate immediately after the solution was delivered. To assess metabolic status, the team employed Nuclear Magnetic Resonance spectroscopy to calculate energetic indices within the left ventricular tissue. Each heart then underwent orthotopic transplantation to observe functional recovery. The team monitored the grafts for two hours after the animals were placed on cardiopulmonary bypass. This experimental design allowed for the direct comparison of vascular performance against metabolic and functional outcomes.
Main Results:
The study identified a significant, progressive decline in initial coronary flow corresponding to longer periods of warm ischemia. Hearts in the control group exhibited a flow rate of 50 +/- 3.4 mL/min per 100 g of tissue. In contrast, groups subjected to ten and twenty minutes of ischemia showed reduced flows of 36 +/- 7 and 30 +/- 3.5 mL/min per 100 g, respectively. Statistical analysis confirmed these differences were significant with P values below .05 and .01. The researchers found a strong correlation between the initial coronary flow and the left ventricular energetic index. This relationship was supported by a correlation coefficient of 0.76 with a P value under .001. Furthermore, the flow measurements accurately predicted the functional performance of the hearts after transplantation. These results confirm that vascular assessment provides a reliable indicator of overall graft viability.
Conclusions:
The researchers propose that initial coronary flow serves as a robust indicator of cardiac graft viability. This measurement offers a practical, reliable alternative to more complex metabolic assessments during the organ procurement process. The study demonstrates that coronary perfusion capacity directly reflects the degree of ischemic injury sustained by the donor heart. These findings suggest that clinicians can use this simple flow test to predict post-transplant functional outcomes. The data indicate a strong correlation between vascular resistance and myocardial energetic status. By providing an objective threshold for viability, this approach may improve the selection of donor hearts. The authors emphasize that this method is easily integrated into standard surgical workflows without requiring specialized equipment. Future clinical application of this technique could enhance the safety and success rates of cardiac transplantation procedures.
Frequently Asked Questions
The researchers propose that initial coronary flow serves as a primary indicator of graft health. They observed that hearts with lower flow rates, specifically 30 mL/min per 100 g of tissue, exhibited poorer performance compared to those with higher flow rates of 50 mL/min per 100 g.
The study utilizes cold cardioplegia solution perfused in a retrograde fashion to stabilize the organ. This technique allows for the precise measurement of coronary flow before the heart is orthotopically transplanted into the recipient.
Retrograde perfusion is necessary to ensure that the cardioplegia solution reaches the coronary vasculature uniformly. This technical step allows for the accurate measurement of initial coronary flow, which would be difficult to standardize using antegrade delivery methods in a harvested heart.
Nuclear Magnetic Resonance spectroscopy provides the energetic indices of the left ventricle. This data type is used to validate the flow measurements by confirming that the vascular performance correlates with the underlying metabolic state of the myocardial tissue.
The researchers measured the initial coronary flow in mL/min per 100 g of tissue. They observed a progressive decline in this flow as the duration of warm ischemia increased from zero to twenty minutes.
The authors propose that this flow-based test provides a reliable, objective criterion for graft acceptance. They suggest that this method could reduce the risk of transplanting hearts with insufficient functional capacity, thereby improving overall patient outcomes.

